Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China Looks To Asia Melon For Curing Diabetes Threat

This article was originally published in PharmAsia News

Executive Summary

Chinese scientists have been dispatched to Australia to work with their counterparts on developing a Western-type drug to cure type 2 diabetes. China faces an explosion of the diabetes cases, expected to double by 2025. Experts from the Shanghai Institute of Materia Medica are joining with Australians to research a non-toxic bitter melon found mostly in Asia. Australian scientists are investigating the possibility of using the melon and other Asian vegetables and fruits as the basis for new drugs. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069421

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel